首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   373976篇
  免费   33652篇
  国内免费   25466篇
耳鼻咽喉   3411篇
儿科学   4163篇
妇产科学   5743篇
基础医学   45545篇
口腔科学   6395篇
临床医学   51009篇
内科学   57509篇
皮肤病学   3700篇
神经病学   20603篇
特种医学   14074篇
外国民族医学   240篇
外科学   39140篇
综合类   57538篇
现状与发展   86篇
一般理论   35篇
预防医学   22994篇
眼科学   10852篇
药学   38029篇
  372篇
中国医学   20036篇
肿瘤学   31620篇
  2024年   1113篇
  2023年   5601篇
  2022年   14491篇
  2021年   18354篇
  2020年   13546篇
  2019年   12178篇
  2018年   12907篇
  2017年   11293篇
  2016年   10714篇
  2015年   16188篇
  2014年   20237篇
  2013年   17895篇
  2012年   26388篇
  2011年   29640篇
  2010年   18446篇
  2009年   14369篇
  2008年   19798篇
  2007年   19908篇
  2006年   19769篇
  2005年   19281篇
  2004年   12780篇
  2003年   11695篇
  2002年   10201篇
  2001年   8958篇
  2000年   9680篇
  1999年   10275篇
  1998年   6135篇
  1997年   6149篇
  1996年   4865篇
  1995年   4371篇
  1994年   3611篇
  1993年   2371篇
  1992年   3268篇
  1991年   2776篇
  1990年   2461篇
  1989年   2176篇
  1988年   1808篇
  1987年   1581篇
  1986年   1292篇
  1985年   1059篇
  1984年   633篇
  1983年   453篇
  1982年   301篇
  1981年   304篇
  1980年   223篇
  1979年   289篇
  1978年   118篇
  1974年   137篇
  1973年   115篇
  1972年   121篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
随着对肿瘤热疗和肿瘤免疫微环境(TIME)的深入研究,近年来热疗对TIME的作用越来越受到学者们的重视。本文就目前国内外研究进展,对热疗与TIME中几类主要免疫细胞和免疫相关细胞因子的影响及作用机制作一综述。全面而透彻的了解热疗对TIME的调控作用,有助于为肿瘤治疗提供新的思路和方法。  相似文献   
83.
Mammalian spermatogenesis is a well-organized process of cell development and differentiation. Meiosis expressed gene 1 (MEIG1) plays an essential role in the regulation of spermiogenesis. To explore potential mechanisms of MEIG1''s action, a yeast two-hybrid screen was conducted, and several potential binding partners were identified; one of them was membrane occupation and recognition nexus repeat containing 3 (MORN3). MORN3 mRNA is only abundant in mouse testis. In the testis, Morn3 mRNA is highly expressed in the spermiogenesis stage. Specific anti-MORN3 polyclonal antibody was generated against N-terminus of the full-length MORN3 protein, and MORN3 expression and localization was examined in vitro and in vivo. In transfected Chinese hamster ovary cells, the antibody specifically crossed-reacted the full-length MORN3 protein, and immunofluorescence staining revealed that MORN3 was localized throughout the cytoplasm. Among multiple mouse tissues, about 25 kDa protein, was identified only in the testis. The protein was highly expressed after day 20 of birth. Immunofluorescence staining on mixed testicular cells isolated from adult wild-type mice demonstrated that MORN3 was expressed in the acrosome in germ cells throughout spermiogenesis. The protein was also present in the manchette of elongating spermatids. The total MORN3 expression and acrosome localization were not changed in the Meig 1-deficient mice. However, its expression in manchette was dramatically reduced in the mutant mice. Our studies suggest that MORN3 is another regulator for spermatogenesis, probably together with MEIG1.  相似文献   
84.
85.
Abstract

Oxidative stress (OS) has been proposed to play a role in the development of EMs. Peroxiredoxins are a family of antioxidant proteins that exhibit peroxidase activity in a thioredoxin-dependent manner, protecting cells against OS. The Western blotting results showed that the relative expression of PRDX4 was significantly increased in ectopic endometria compared with the normal endometria of EMs-free (p?<?.05). The H2O2 concentration was also significantly higher in the ectopic endometrium. PRDX4 siRNA was transfected into primary ectopic endometrial stromal cells (EESCs). The viability of the transfected EESCs was measured by CCK-8 assay, and the results showed significantly decreased cell viability. Furthermore, the apoptosis rate and ROS generation in flow cytometry assays were significantly increased after the knockdown of PRDX4 expression (p?<?.05). Scratch assays and transwell assays revealed that decreased expression of PRDX4 mediated by siRNA inhibited EESC migration and invasion. In conclusion, these findings indicate the potential role of PRDX4 in the development of EMs and PRDX4 as a possible therapeutic target for EMs treatment.  相似文献   
86.
87.
电子医疗数据已成为大数据时代开展药品安全主动监测的重要资源。基于此确认药品与不良事件是否存在关联,要回归传统的流行病学研究设计,选取恰当的对照进行对比。本文主要阐述不同对照选取的原理、适用情形,介绍、评价并比较各种对照选取的思路与参数,引入对照选择批量化实现的进展性成果,以期为我国利用电子医疗数据开展上市后药品安全性监测提供方法学参考。  相似文献   
88.
89.
Background: Previous genome-wide association study (GWAS) has revealed the association between MYP10 at 8p23 and MYP15 at 10q21.1 and high myopia (HM) in a French population. This study is managed to discover the connection between some single nucleotide polymorphism (located at MYP10 and MYP15) and Han Chinese HM.

Methods and Results: This case-control association study contained 1673 samples, including 869 ophthalmic patients and 804 controls. Twelve tag SNPs have been selected from the MYP10 and MYP15 loci and genotyped by SNaPshot method. Among 12 SNPs, rs4840437 and rs6989782 in TNKS gene were found significant association with HM. Carriers of rs4840437G allele and rs4840437GG genotype created a low risk of high myopia (P = .036, OR = 0.81, 95%CI = 0.71–0.93; P = .016, OR = 0.73, 95%CI = 0.56–0.96; respectively). Carriers of rs6989782T allele and rs6989782TT+CT genotype also had a decreased risk of high myopia (P = .048, OR = 0.82, 95%CI = 0.71–0.94; P = .006, OR = 0.74, 95%CI = 0.59–0.92; respectively). Other 10 SNPs displaced nonsignificant association with HM. Additionally, the risk haplotype AC and the protective haplotype GT, generated by two SNPs in TNKS, were considerably more likely to be association with HM (for AC, P = .002 and OR = 1.26; for GT, P = .027 and OR = 0.84).

Conclusions: Our results demonstrated that some heritable variants in the TNKS gene are associated with HM in the Han population. The possible functions of TNKS in the development and pathogenesis of hereditary high myopia still require further researches to identify.  相似文献   

90.
王翔 《中国药物评价》2019,36(5):392-396
目的:通过研究风险评估工具,结合企业临床试验数据管理风险评估实例,从实际应用角度出发,提出完善药物临床试验数据管理过程中应用风险评估的意见建议。方法:运用文献分析方法、案例分析法,分析和借鉴成功的经验。结果与结论:我国的药品研制单位应根据具体临床试验特点和法规要求,利用合适的风险管理工具,对临床试验数据管理过程进行评估,根据评估结果合理制定并实施数据管理策略,达到保证临床试验数据完整、可靠的目的。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号